These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30220228)

  • 1. Nonbiological therapeutic management of ulcerative colitis.
    Mezzina N; Campbell Davies SE; Ardizzone S
    Expert Opin Pharmacother; 2018 Nov; 19(16):1747-1757. PubMed ID: 30220228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there room for immunomodulators in ulcerative colitis?
    Chhibba T; Ma C
    Expert Opin Biol Ther; 2020 Apr; 20(4):379-390. PubMed ID: 31874578
    [No Abstract]   [Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance therapy options for ulcerative colitis.
    Chaparro M; Gisbert JP
    Expert Opin Pharmacother; 2016 Jul; 17(10):1339-49. PubMed ID: 27240112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.
    Regueiro M; Loftus EV; Steinhart AH; Cohen RD
    Inflamm Bowel Dis; 2006 Oct; 12(10):979-94. PubMed ID: 17012969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis.
    Jackson B; De Cruz P
    Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1079-1100. PubMed ID: 30284911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the management of ulcerative colitis.
    Taba Taba Vakili S; Taher M; Ebrahimi Daryani N
    Acta Med Iran; 2012; 50(6):363-72. PubMed ID: 22837114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date.
    Thukral C; Cheifetz A; Peppercorn MA
    Drugs; 2006; 66(16):2059-65. PubMed ID: 17112300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard treatment of ulcerative colitis.
    Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
    Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy.
    Iizuka M; Etou T; Sagara S
    World J Gastroenterol; 2022 Sep; 28(34):4959-4972. PubMed ID: 36160647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
    Singh S; Allegretti JR; Siddique SM; Terdiman JP
    Gastroenterology; 2020 Apr; 158(5):1465-1496.e17. PubMed ID: 31945351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.
    Bressler B; Marshall JK; Bernstein CN; Bitton A; Jones J; Leontiadis GI; Panaccione R; Steinhart AH; Tse F; Feagan B;
    Gastroenterology; 2015 May; 148(5):1035-1058.e3. PubMed ID: 25747596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive and biologic therapy for ulcerative colitis.
    Ardizzone S; Cassinotti A; de Franchis R
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):449-67. PubMed ID: 23163556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A current overview of corticosteroid use in active ulcerative colitis.
    Salice M; Rizzello F; Calabrese C; Calandrini L; Gionchetti P
    Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):557-561. PubMed ID: 30947569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab in ulcerative colitis - efficacy, safety and optimization in the era of treat-to target.
    Sparrow MP
    Expert Opin Biol Ther; 2017 May; 17(5):613-621. PubMed ID: 28316250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical therapy of inflammatory bowel diseases: ulcerative colitis].
    Lakatos L; Lakatos PL
    Orv Hetil; 2007 Jun; 148(25):1163-70. PubMed ID: 17573252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current pharmacologic therapies and emerging alternatives in the treatment of ulcerative colitis.
    Nakamura T; Nagahori M; Kanai T; Watanabe M
    Digestion; 2008; 77 Suppl 1():36-41. PubMed ID: 18204260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy.
    Colombel JF; Jharap B; Sandborn WJ; Feagan B; Peyrin-Biroulet L; Eichner SF; Robinson AM; Mostafa NM; Zhou Q; Thakkar RB
    Aliment Pharmacol Ther; 2017 Jan; 45(1):50-62. PubMed ID: 27883215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.